维普中文期刊产品整合服务
15篇 您的检索式:作者名="Ferraccioli GF"
    题名 作者 年代 出处 被引量
1Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy:a randomized controlled trial显示文摘Ferraro PM Ferraccioli GF Gambaro G 2009Nephrol Dial Transplant2009,24,:1
2Autoantibodies and thrombophilia in RA: TNF and TNF blockers显示文摘Ferraccioli GF Gremese E 2004Annals of the Rheumatic Diseases2004,63,:1
3Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy:a randomized controlled trial显示文摘Ferraro PM Ferraccioli GF Gambaro G Neprhol Dial Tran0,,:1
4Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy:a randomized controlled trial显示文摘Ferraro PM Ferraccioli GF Gambaro G 0,,01:1
5Tiopronin-nephropathy: clinical, pathological, immunological and immunogenetic characteristics显示文摘Ferraccioli GF Peri F Nervetti A 1986Clin Exp Rheumatol1986,4,1:1
6Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropatby: a randomized controlled trial显示文摘Ferraro PM Ferraccioli GF Gambaro G 2009Nephrol Dial Transplant2009,24,1:1
7Clinical features, scintiscan characteristics and X-ray pro- gression of late onset rheumatoid arthritis 显示文摘Ferraccioli GF Cavalieri F Mercadanti M 1984Clin Exp Rheumatol1984,2,2:1
8Biosimilars in rheumatology: pharmacological and pharmacoeconomic issues显示文摘Lapadula G Ferraccioli GF 2012Clin Exp Rheumatol2012,30,473:1
9High dose intravenous immunglobulins therapyfor rheumatic disease:clinic relevance and personal experience显示文摘 Ferraccioli GF Dipoi E 1996Clin Exp Rheum1996,14,:1
10Combined treatment with renin-angiotensin system blockers and polyunsaturated fatty acids in proteinuric IgA nephropathy:a randomized controlled trial显示文摘Ferraro PM Ferraccioli GF Gambaro G 0,,:1
11Discriminating ability of composite indices for measuring disease activity in rheumatoid arthritis:a comparison of the Chronic Arthritis Systemic Index,Disease Activity Score and Thompson's articular index显示文摘Salaffi F Peroni M Ferraccioli GF 2000Rheumatology(Oxfo- rd)2000,39,1:1
12Analysis of improvements, full responses, remission and toxicity in rheumatoid patients treated with step-up combination therapy (methotrexate, cyclosporin A, sulphasalazine) or monotherapy for three years显示文摘Ferraccioli GF Gremese E Tomoetto P 2002Rheumatology (Oxford)2002,41,8:1
13CD4 cytopenia and occasional expansion of CD4 + CD8 + lymphocytes in Sjogren' s syndrome 显示文摘Ferraccioli GF Tonutti E Casatta L 1996Clin - Exp - Rheumatol1996,14,2:1
14Benefit/risk of cyclosporine in rheumatoid arthritis显示文摘Gremese E Ferraccioli GF 2004Clin Exp Rheumatol2004,22,5135:1
15Discriminating ability of composite indices for measuring disease activity in rheumatoid arthritis: a comparison of the Chronic Arthritis Systemic index, Disease Activity Score and Thompson's Articular Index显示文摘Salaffi F Peroni M Ferraccioli GF 2000Rheumatology2000,39,1:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费